WOCKPHARMA

Q4 2025 Result Analysis

Q4 2025 Result Analysis In Q4FY25, Wockhardt Ltd reported a marginal decline in revenue to ₹743 crore from ₹750 crore YoY, but registered a 13% QoQ growth in EBITDA, reaching ₹79 crore. This indicates improved operational efficiency despite flat top-line performance during the quarter. For the full year FY25, Wockhardt delivered a steady revenue growth of 5.3% YoY to ₹3,033 crore. More notably, EBITDA jumped significantly by 67% YoY to ₹418 crore, suggesting a strong improvement in profitability and cost control throughout the year. Conclusion: Wockhardt’s FY25 results reflect a strong turnaround in operational performance, driven by significant EBITDA expansion despite moderate revenue growth. The sharp improvement in profitability highlights better efficiency and margin management, marking a positive trajectory for the company.